Citation Information: JCI Insight. 2021. https://doi.org/10.1172/jci.insight.148768.
Abstract
Sarcomas contain a subpopulation of tumor propagating cells (TPCs) with enhanced tumor-initiating and self-renewal properties. However, it is unclear whether the TPC phenotype in sarcomas is stable or a dynamic cell state that can derive from non-tumor propagating cells (non-TPCs). In this study, we utilized a mouse model of undifferentiated pleomorphic sarcoma (UPS) to trace the lineage relationship between sarcoma side population (SP) cells that are enriched for TPCs and non-side population (non-SP) cells. By co-transplanting SP and non-SP cells expressing different endogenous fluorescent reporters, we show that non-SP cells can give rise to SP cells with enhanced tumor propagating potential in-vivo. Lineage trajectory analysis using single-cell RNA sequencing from SP and non-SP cells supports the notion that non-SP cells can assume the SP cell phenotype de novo. To test the effect of eradicating SP cells on tumor growth and self-renewal, we generated mouse sarcomas in which the Diphtheria Toxin Receptor (DTR) is expressed in the SP cells and their progeny. Ablation of the SP population using diphtheria toxin (DT) did not impede tumor growth or self-renewal. Together, we show that sarcoma SP is a dynamic cell state and targeting TPCs alone is insufficient to eliminate tumor progression.
Authors
Yuning Jackie Tang, Vijitha Puviindran, Yu Xiang, Yasuhito Yahara, Hongyuan Zhang, Puviindran Nadesan, Yarui Diao, David G. Kirsch, Benjamin A. Alman
